TipRanks
Advertisement
Advertisement

JBIO Stock Latest News

Jade Biosciences: Pipeline Catalysts and JADE301 Potential Support Appealing Risk-Reward; Buy Rating Reiterated with Unchanged $42 Price Target
RatingsJade Biosciences: Pipeline Catalysts and JADE301 Potential Support Appealing Risk-Reward; Buy Rating Reiterated with Unchanged $42 Price Target
10d ago
JBIO
Jade Biosciences advances JADE301 toward Phase 1 trial
PremiumCompany Announcements
Jade Biosciences advances JADE301 toward Phase 1 trial
10d ago
8K
JBIO
Jade Biosciences announces preclinical data of JADE301
PremiumThe Fly
Jade Biosciences announces preclinical data of JADE301
10d ago
JBIO
Climb Bio price target raised to $25 from $18 at Oppenheimer
PremiumThe Fly
Climb Bio price target raised to $25 from $18 at Oppenheimer
1M ago
CLYM
JBIO
Jade Biosciences price target raised to $48 from $25 at Clear Street
PremiumThe Fly
Jade Biosciences price target raised to $48 from $25 at Clear Street
1M ago
CLYM
JBIO
Jade Biosciences price target raised to $48 from $40 at Jefferies
PremiumThe FlyJade Biosciences price target raised to $48 from $40 at Jefferies
2M ago
JBIO
Jade Biosciences price target raised to $47 from $45 at Wedbush
Premium
The Fly
Jade Biosciences price target raised to $47 from $45 at Wedbush
2M ago
JBIO
Analyst Julian Harrison Lifts Jade Biosciences Price Target to $77 and Reiterates Buy on Strong Pipeline and De-Risked IgA Program
Premium
Ratings
Analyst Julian Harrison Lifts Jade Biosciences Price Target to $77 and Reiterates Buy on Strong Pipeline and De-Risked IgA Program
2M ago
JBIO
Jade Therapeutics: Buy Rating Reiterated as Strong Cash Position and Pipeline Progress Support Unchanged $42 Price Target
PremiumRatings
Jade Therapeutics: Buy Rating Reiterated as Strong Cash Position and Pipeline Progress Support Unchanged $42 Price Target
2M ago
JBIO
Jade Biosciences reports Q2 EPS (76c) vs. (86c) last year
PremiumThe Fly
Jade Biosciences reports Q2 EPS (76c) vs. (86c) last year
2M ago
JBIO
Nuvectis’ NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor
PremiumTipRanks Newswire
Nuvectis’ NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor
3M ago
NVS
CRNX
The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush
PremiumTipRanks Newswire
The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush
3M ago
LLY
ABBV
Jade Biosciences Secures Exclusive Antibody License Agreement
PremiumCompany AnnouncementsJade Biosciences Secures Exclusive Antibody License Agreement
3M ago
8K
JBIO
Jade Biosciences Adds Veteran Biopharma Leader to Board
Premium
Company Announcements
Jade Biosciences Adds Veteran Biopharma Leader to Board
4M ago
8K
JBIO
BTIG says others may be interested in Apogee Therapeutics
Premium
The Fly
BTIG says others may be interested in Apogee Therapeutics
4M ago
JNJ
NVS
Jade Biosciences initiated with a Buy at UBS
PremiumThe Fly
Jade Biosciences initiated with a Buy at UBS
4M ago
JBIO
Jade Biosciences Shareholders Approve Governance and Audit Measures
PremiumCompany Announcements
Jade Biosciences Shareholders Approve Governance and Audit Measures
4M ago
8K
JBIO
Jade Biosciences Launches Major Underwritten Equity Offering
PremiumCompany Announcements
Jade Biosciences Launches Major Underwritten Equity Offering
4M ago
8K
JBIO
JADE101 Phase 1 Trial Marks Key Early Milestone for Jade Biosciences Investors
PremiumCompany Announcements
JADE101 Phase 1 Trial Marks Key Early Milestone for Jade Biosciences Investors
4M ago
JBIO
Jade Biosciences 10M share Secondary priced at $15.00
PremiumThe FlyJade Biosciences 10M share Secondary priced at $15.00
4M ago
JBIO
Jade Biosciences announces common stock offering, no amount given
Premium
The Fly
Jade Biosciences announces common stock offering, no amount given
4M ago
JBIO
Jade Biosciences price target raised to $47 from $32 at Guggenheim
Premium
The Fly
Jade Biosciences price target raised to $47 from $32 at Guggenheim
4M ago
JBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >